REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 62 filers reported holding REPROS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,601,000 | +257.3% | 350,000 | +243.5% | 0.22% | +406.8% |
| Q2 2015 | $728,000 | -71.3% | 101,881 | -65.5% | 0.04% | -71.8% |
| Q1 2015 | $2,534,000 | -45.5% | 295,000 | -36.7% | 0.16% | -71.6% |
| Q4 2014 | $4,646,000 | +1773.4% | 466,000 | +1764.0% | 0.55% | +3566.7% |
| Q3 2014 | $248,000 | -93.3% | 25,000 | -88.2% | 0.02% | -94.4% |
| Q2 2014 | $3,676,000 | +40.5% | 212,500 | +44.1% | 0.27% | +39.4% |
| Q1 2014 | $2,617,000 | -60.3% | 147,500 | -59.0% | 0.19% | -76.7% |
| Q4 2013 | $6,587,000 | -47.0% | 360,000 | -22.4% | 0.83% | -29.0% |
| Q3 2013 | $12,435,000 | +14.9% | 464,000 | -20.9% | 1.16% | +5.4% |
| Q2 2013 | $10,818,000 | – | 586,375 | – | 1.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allegis Investment Advisors, LLC | 342,709 | $569,000 | 0.29% |
| GENERAL AMERICAN INVESTORS CO INC | 396,123 | $638,000 | 0.07% |
| Alambic Investment Management, L.P. | 69,191 | $111,000 | 0.03% |
| Acrospire Investment Management LLC | 15,119 | $24,000 | 0.02% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 98,486 | $158,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 315,030 | $507,000 | 0.01% |
| SIMPLEX TRADING, LLC | 86,054 | $138,000 | 0.01% |
| A.R.T. Advisors, LLC | 34,315 | $55,000 | 0.00% |
| Mariner Wealth Advisors-Cincinnati, LLC | 11,000 | $18,000 | 0.00% |
| Renaissance Technologies | 561,713 | $904,000 | 0.00% |